Report of Foreign Issuer (6-k)
18 Janeiro 2019 - 8:09PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE
SECURITIES EXCHANGE ACT OF 1934
For the month of January 2019
Commission File Number: 001-36403
IKANG HEALTHCARE GROUP, INC.
(Exact name of registrant as specified in its charter)
B-6F, Shimao Tower
92A Jianguo Road
Chaoyang District, Beijing 100022
Peoples Republic of China
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F
x
Form 40-F
o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
o
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
IKANG HEALTHCARE GROUP, INC.
|
|
|
|
|
By:
|
/s/ YANG CHEN
|
|
Name:
|
Yang Chen
|
|
Title:
|
Chief Financial Officer
|
Date: January 18, 2019
2
Exhibit Index
Exhibit 99.1
|
|
iKang Announces Completion of Going Private Transaction
|
3
IKANG HEALTHCARE GROUP, INC. (NASDAQ:KANG)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
IKANG HEALTHCARE GROUP, INC. (NASDAQ:KANG)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Ikang Healthcare Grp. ADS da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Ikang Healthcare Group, Inc.